154 related articles for article (PubMed ID: 32237256)
21. Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.
Adamowicz K
Qual Life Res; 2017 Apr; 26(4):813-822. PubMed ID: 27738867
[TBL] [Abstract][Full Text] [Related]
22. [Health-related quality of life in phase III cancer clinical trials: from questionnaire administration to statistical analysis].
Fiteni F; Anota A; Westeel V; Bonnetain F
Bull Cancer; 2015 Apr; 102(4):360-6. PubMed ID: 25799875
[TBL] [Abstract][Full Text] [Related]
23. Health-related quality of life in trials with high rates of early censoring: Caution advised.
Olivier T; Haslam A; Prasad V
Eur J Cancer; 2024 Jul; 205():114105. PubMed ID: 38718724
[TBL] [Abstract][Full Text] [Related]
24. International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience.
Bottomley A; Aaronson NK;
J Clin Oncol; 2007 Nov; 25(32):5082-6. PubMed ID: 17991925
[TBL] [Abstract][Full Text] [Related]
25. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.
Bottomley A; Pe M; Sloan J; Basch E; Bonnetain F; Calvert M; Campbell A; Cleeland C; Cocks K; Collette L; Dueck AC; Devlin N; Flechtner HH; Gotay C; Greimel E; Griebsch I; Groenvold M; Hamel JF; King M; Kluetz PG; Koller M; Malone DC; Martinelli F; Mitchell SA; Moinpour CM; Musoro J; O'Connor D; Oliver K; Piault-Louis E; Piccart M; Pimentel FL; Quinten C; Reijneveld JC; Schürmann C; Smith AW; Soltys KM; Taphoorn MJB; Velikova G; Coens C;
Lancet Oncol; 2016 Nov; 17(11):e510-e514. PubMed ID: 27769798
[TBL] [Abstract][Full Text] [Related]
26. Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG.
Au HJ; Ringash J; Brundage M; Palmer M; Richardson H; Meyer RM;
Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):119-28. PubMed ID: 20384559
[TBL] [Abstract][Full Text] [Related]
27. Strategies to improve success of pediatric cancer cooperative group quality of life studies: a report from the Children's Oncology Group.
Whitlow PG; Caparas M; Cullen P; Trask C; Schulte F; Embry L; Nagarajan R; Johnston DL; Sung L
Qual Life Res; 2015 Jun; 24(6):1297-301. PubMed ID: 25429821
[TBL] [Abstract][Full Text] [Related]
28. Economic Evaluations in National Cancer Institute-Sponsored Network Cancer Clinical Trials.
Nghiem VT; Vaidya R; Lyman GH; Hershman DL; Ramsey SD; Unger JM
Value Health; 2020 Dec; 23(12):1653-1661. PubMed ID: 33248521
[TBL] [Abstract][Full Text] [Related]
29. Effect of different types of exercise on health-related quality of life during and after cancer treatment: a protocol for a systematic review and network meta-analysis.
Ubago-Guisado E; Gracia-Marco L; Cavero-Redondo I; Martinez-Vizcaino V; Notario-Pacheco B; Pozuelo-Carrascosa DP; Adalia EG; Álvarez-Bueno C
BMJ Open; 2019 Nov; 9(11):e031374. PubMed ID: 31685509
[TBL] [Abstract][Full Text] [Related]
30. Insights From Building a New National Cancer Institute Community Oncology Research Program Site.
Saphner T; Thompson MA; Planton S; Singh M; Glandt N; Robinson L; DeBartolo J
WMJ; 2016 Aug; 115(4):191-5. PubMed ID: 29099156
[TBL] [Abstract][Full Text] [Related]
31. Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.
Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Novello S; Aglietta M; Scagliotti GV; Perrone F; Di Maio M
Ann Oncol; 2018 Dec; 29(12):2288-2295. PubMed ID: 30304498
[TBL] [Abstract][Full Text] [Related]
32. Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review.
Fiteni F; Anota A; Westeel V; Bonnetain F
BMC Cancer; 2016 Feb; 16():122. PubMed ID: 26892541
[TBL] [Abstract][Full Text] [Related]
33. Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectiveness.
Pickett K; Loveman E; Kalita N; Frampton GK; Jones J
Health Technol Assess; 2015 Oct; 19(86):1-176, v-vi. PubMed ID: 26502807
[TBL] [Abstract][Full Text] [Related]
34. Health-Related Quality of Life Data in Cancer Clinical Trials for Drug Registration: The Value Beyond Reimbursement.
Wasalski E; Mehta S
JCO Clin Cancer Inform; 2021 Jan; 5():112-124. PubMed ID: 33492993
[TBL] [Abstract][Full Text] [Related]
35. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?
Efficace F; Bottomley A; Osoba D; Gotay C; Flechtner H; D'haese S; Zurlo A
J Clin Oncol; 2003 Sep; 21(18):3502-11. PubMed ID: 12972527
[TBL] [Abstract][Full Text] [Related]
36. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
37. Perceived impact of cancer among adolescents and young adults: Relationship with health-related quality of life and distress.
Husson O; Zebrack BJ
Psychooncology; 2017 Sep; 26(9):1307-1315. PubMed ID: 27862627
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations.
Kvam AK; Fayers P; Hjermstad M; Gulbrandsen N; Wisloff F
Eur J Haematol; 2009 Oct; 83(4):279-89. PubMed ID: 19558508
[TBL] [Abstract][Full Text] [Related]
39. Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock.
Goodwin PJ; Black JT; Bordeleau LJ; Ganz PA
J Natl Cancer Inst; 2003 Feb; 95(4):263-81. PubMed ID: 12591983
[TBL] [Abstract][Full Text] [Related]
40. The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation.
Frampton G; Harris P; Cooper K; Lotery A; Shepherd J
Health Technol Assess; 2014 Nov; 18(68):1-205, v-vi. PubMed ID: 25405576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
